(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 33.33% in 21 sessions from €8.7 to €5.80 at 02:37 EST on Friday, after five sequential sessions in a row of losses. CAC 40 is sliding 0.85% to €7,340.77, following the last session’s upward trend.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
More news about ABL Diagnostics (ABLD.PA).
